These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
530 related articles for article (PubMed ID: 17240304)
1. Diagnostic morphological features of PDGFRA-mutated gastrointestinal stromal tumors: molecular genetic and histologic analysis of 60 cases of gastric gastrointestinal stromal tumors. Daum O; Grossmann P; Vanecek T; Sima R; Mukensnabl P; Michal M Ann Diagn Pathol; 2007 Feb; 11(1):27-33. PubMed ID: 17240304 [TBL] [Abstract][Full Text] [Related]
2. Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases. Miettinen M; Sobin LH; Lasota J Am J Surg Pathol; 2009 Sep; 33(9):1267-75. PubMed ID: 19440146 [TBL] [Abstract][Full Text] [Related]
3. The analysis of status and clinical implication of KIT and PDGFRA mutations in gastrointestinal stromal tumor (GIST). Du CY; Shi YQ; Zhou Y; Fu H; Zhao G J Surg Oncol; 2008 Sep; 98(3):175-8. PubMed ID: 18618605 [TBL] [Abstract][Full Text] [Related]
4. PDGFRA immunostaining can help in the diagnosis of gastrointestinal stromal tumors. Miselli F; Millefanti C; Conca E; Negri T; Piacenza C; Pierotti MA; Tamborini E; Pilotti S Am J Surg Pathol; 2008 May; 32(5):738-43. PubMed ID: 18360281 [TBL] [Abstract][Full Text] [Related]
5. The location of KIT and PDGFRA gene mutations in gastrointestinal stromal tumours is site and phenotype associated. Penzel R; Aulmann S; Moock M; Schwarzbach M; Rieker RJ; Mechtersheimer G J Clin Pathol; 2005 Jun; 58(6):634-9. PubMed ID: 15917417 [TBL] [Abstract][Full Text] [Related]
6. [c-Kit and PDGFRA mutations and clinico-morphological features of gastrointestinal stromal tumors]. Beliakov IS; Anurova OA; Snigur PV; Tsyganova IV; Sel'chuk VIu; Mazurenko NN Vopr Onkol; 2007; 53(6):677-81. PubMed ID: 18416137 [TBL] [Abstract][Full Text] [Related]
7. KIT-negative gastrointestinal stromal tumor of the abdominal soft tissue: a clinicopathologic and genetic study of 10 cases. Yamamoto H; Kojima A; Nagata S; Tomita Y; Takahashi S; Oda Y Am J Surg Pathol; 2011 Sep; 35(9):1287-95. PubMed ID: 21836495 [TBL] [Abstract][Full Text] [Related]
8. Gastrointestinal stromal tumours (GISTs) negative for KIT (CD117 antigen) immunoreactivity. Debiec-Rychter M; Wasag B; Stul M; De Wever I; Van Oosterom A; Hagemeijer A; Sciot R J Pathol; 2004 Apr; 202(4):430-8. PubMed ID: 15095270 [TBL] [Abstract][Full Text] [Related]
9. Low frequency of MAP kinase pathway alterations in KIT and PDGFRA wild-type GISTs. Martinho O; Gouveia A; Viana-Pereira M; Silva P; Pimenta A; Reis RM; Lopes JM Histopathology; 2009 Jul; 55(1):53-62. PubMed ID: 19614767 [TBL] [Abstract][Full Text] [Related]
10. "Pediatric-type" gastrointestinal stromal tumors in adults: distinctive histology predicts genotype and clinical behavior. Rege TA; Wagner AJ; Corless CL; Heinrich MC; Hornick JL Am J Surg Pathol; 2011 Apr; 35(4):495-504. PubMed ID: 21358303 [TBL] [Abstract][Full Text] [Related]
11. Pediatric KIT wild-type and platelet-derived growth factor receptor alpha-wild-type gastrointestinal stromal tumors share KIT activation but not mechanisms of genetic progression with adult gastrointestinal stromal tumors. Janeway KA; Liegl B; Harlow A; Le C; Perez-Atayde A; Kozakewich H; Corless CL; Heinrich MC; Fletcher JA Cancer Res; 2007 Oct; 67(19):9084-8. PubMed ID: 17909012 [TBL] [Abstract][Full Text] [Related]
13. Molecular and clinicopathologic characterization of gastrointestinal stromal tumors (GISTs) of small size. Rossi S; Gasparotto D; Toffolatti L; Pastrello C; Gallina G; Marzotto A; Sartor C; Barbareschi M; Cantaloni C; Messerini L; Bearzi I; Arrigoni G; Mazzoleni G; Fletcher JA; Casali PG; Talamini R; Maestro R; Dei Tos AP Am J Surg Pathol; 2010 Oct; 34(10):1480-91. PubMed ID: 20861712 [TBL] [Abstract][Full Text] [Related]
14. [Status and clinical analysis of c-kit and PDGFRA mutations in the gastrointestinal stromal tumors]. Du CY; Shi YQ; Zhou Y; Fu H; Zhao GF Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Jul; 11(4):371-5. PubMed ID: 18636362 [TBL] [Abstract][Full Text] [Related]
15. Analysis of mutation and expression of c-kit and PDGFR-alpha gene in gastrointestinal stromal tumor. Zheng S; Chen LR; Wang HJ; Chen SZ Hepatogastroenterology; 2007 Dec; 54(80):2285-90. PubMed ID: 18265649 [TBL] [Abstract][Full Text] [Related]
16. Molecular alterations of KIT and PDGFRA in GISTs: evaluation of a Portuguese series. Gomes AL; Gouveia A; Capelinha AF; de la Cruz D; Silva P; Reis RM; Pimenta A; Lopes JM J Clin Pathol; 2008 Feb; 61(2):203-8. PubMed ID: 17827398 [TBL] [Abstract][Full Text] [Related]
17. Intestinal neurofibromatosis is a subtype of familial GIST and results from a dominant activating mutation in PDGFRA. de Raedt T; Cools J; Debiec-Rychter M; Brems H; Mentens N; Sciot R; Himpens J; de Wever I; Schöffski P; Marynen P; Legius E Gastroenterology; 2006 Dec; 131(6):1907-12. PubMed ID: 17087943 [TBL] [Abstract][Full Text] [Related]
18. PDGFRalpha- and c-kit-mutated gastrointestinal stromal tumours (GISTs) are characterized by distinctive histological and immunohistochemical features. Pauls K; Merkelbach-Bruse S; Thal D; Büttner R; Wardelmann E Histopathology; 2005 Feb; 46(2):166-75. PubMed ID: 15693889 [TBL] [Abstract][Full Text] [Related]
19. Clinicopathology and molecular diagnostics of gastrointestinal stromal tumors. Lucas DR Curr Probl Cancer; 2011; 35(5):233-44. PubMed ID: 22118563 [No Abstract] [Full Text] [Related]